Financials

	2024	2025
Net sales	492K 430K 397K 367K 696K 46.92M 707K 4.74M 1.86M 23.12M 1.85M 1.81M 79.47M	89K 77.85K 71.81K 66.32K 126K 8.49M 128K 858K 337K 4.18M 334K 327K 14.38M
Net income	-1.04M -910K -839K -775K -1.47M -99.19M -1.5M -10.03M -3.94M -48.86M -3.9M -3.82M -168M	-3.98M -3.48M -3.21M -2.96M -5.62M -379M -5.72M -38.33M -15.05M -187M -14.93M -14.6M -642M
Net Debt	6.22M 5.44M 5.02M 4.63M 8.79M 593M 8.94M 59.93M 23.54M 292M 23.34M 22.84M 1B	911K 797K 735K 679K 1.29M 86.89M 1.31M 8.78M 3.45M 42.8M 3.42M 3.35M 147M

* Estimated data More financial data

Company Profile

DXI Capital Corp. is a Canada-based company. The Company has no active operations. It does not generate revenue from its operations. The Companyâ€™s wholly owned subsidiary is 0855524 B.C. Ltd.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
26-07-10	$0.3000	+7.14%	2,000
26-07-09	$0.2800	+21.74%	12,000

Delayed Quote Toronto S.E.

More quotes

Income Statement and Estimates

More financial data

Market Closed - Toronto S.E. Other stock markets 15:48:46 2026-07-10 EDT			5-day change	1st Jan Change
0.3000 ^CAD	+7.14%		+30.43%	-

06-30	VVT Med Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
06-30	VVT Med Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Market Cap	15.4M 13.47M 12.43M 11.48M 21.78M 1.47B 22.14M 148M 58.31M 724M 57.83M 56.57M 2.49B	P/E 2024 *	-	P/E 2025	-2.71x
Enterprise Value	16.31M 14.27M 13.16M 12.16M 23.07M 1.56B 23.45M 157M 61.76M 766M 61.25M 59.92M 2.63B	EV / Sales 2024 *	-	EV / Sales 2025	175x
Free-Float	-	Yield 2024 *	-	Yield 2025	-

06-30	VVT Med Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
06-30	VVT Med Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
06-29	VVT Med Inc. Auditor Raises 'Going Concern' Doubt	CI
06-26	VVT Med Signs Exclusive Distribution Deal in Greece Worth About C$1.14 Million	MT
06-26	VVT Med Inc. Enters Exclusive Distribution Agreement With General Chemical Products S.A. For ScleroSafe Platform In Greece	CI
06-11	VVT Med Enters Dominican Republic Market	MT
06-11	VVT Med Inc. Expands into the Dominican Republic, Appointing Antilles Medical as Exclusive Distributor	CI
05-26	VVT Med Announces First Patients Treated with VVT?s ScleroSafe System in Italy	CI
04-30	VVT Med Inc Announces Positive Clinical Data For ScleroSafe Catheter-Directed Sclerotherapy System	CI
04-27	VVT Med Signs "Largest" European Distribution Agreement to Date	MT
04-27	VVT Med Inc. Signs Exclusive Distribution Agreement With Uber Ros S.p.A. For ScleroSafe System In Italy, Vatican City And Republic Of San Marino	CI
04-22	VVT Med Closes First Tranche In Private Placement of Units	MT
03-17	VVT Med Inc. announced that it expects to receive $3.000001 million in funding	CI

06-26	VVT Med Expands European Commercial Footprint Through Exclusive Distribution Agreement in Greece	AQ
06-12	VVT Med Provides Update on Management Cease Trade Order	AQ
06-11	VVT Med Expands into the Dominican Republic, Appointing Antilles Medical as Exclusive Distributor	GL
05-29	VVT Med Provides Update on Management Cease Trade Order	AQ
05-26	VVT Med Announces First Patients Treated with VVT’s ScleroSafe™ System in Italy	GL

VVT Med Inc. Stock

Stocks

VVTM

CA91841T1084

Medical Equipment, Supplies & Distribution

Valuation: VVT Med Inc.

Chart: VVT Med Inc.

Latest news : VVT Med Inc.

Press Releases: VVT Med Inc.

News in other languages: VVT Med Inc.

Quotes and Performance

Course Extremes

Latest insider transactions

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Quotes

Income Statement and Estimates

11-26	VVT Medical Inc. (VVTM) ouvre les marchés
23-11-23	Sopra Steria Group: Willy il Coyote cerca di tenere il passo con Bip Bip
23-11-23	Sopra Steria Group: Coyote intenta seguir el ritmo de Bip Bip
23-11-23	Sopra Steria Group : le Coyote tente de suivre Bip Bip

1 day	+7.14%
1 week	+30.43%
Current month	+30.43%
1 month	+36.36%
3 months	+20.00%
6 months	-11.76%

1 week	0.23	0.3
1 month	0.2	0.3
Current year	0.17	0.45
1 year	0.15	0.56
3 years	0.15	0.56
5 years	0.15	0.56
10 years	0.15	0.56

Date	Insider	Type	Main position	% Market Cap.
04-27	Erez Tetro	Other	Chief Executive Officer	0%
04-26	Yair Aloni	Other	Chairman	0%
04-26	Yair Aloni	Other	Chairman	0%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VVT MED INC.	+7.14%	+30.43%	-	-	15.4M
ABBOTT LABORATORIES	-0.50%	-1.54%	-28.85%	-12.09%	164B
MEDTRONIC PLC	+1.80%	+0.82%	-6.73%	-4.23%	107B
CENCORA, INC.	+0.32%	+2.34%	+2.79%	+59.04%	59.04B
HOYA CORPORATION	+2.02%	-0.37%	+40.23%	+55.65%	51.72B
BECTON, DICKINSON AND COMPANY	+0.72%	-3.88%	-13.66%	-41.26%	41.87B
MEDLINE INC.	+0.47%	-4.98%	-	-	34.7B
DEXCOM, INC.	+2.66%	+5.21%	-10.09%	-43.92%	28.93B
WEST PHARMACEUTICAL SERVICES, INC.	-1.10%	-3.29%	+55.70%	-7.77%	24.99B
STERIS PLC	0.00%	-1.01%	-5.28%	-4.72%	21.05B
Average	+1.35%	-1.00%	+4.26%	+0.09%	53.33B
Weighted average by Cap.	+0.62%	-0.95%	-5.58%	+1.28%